27 completed. 27 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 27 | Completed 27 |
Follow ADHD: new trials by email Literature Review of ADHD trials Research Report on ADHD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Treatment of ADHD in Children With Down Syndrome Quillivant XR, Placebo - Down Syndrome, ADHD | Phase 4 | Completed | Children's Hospital Medical Center, Cincinnati | 44 | 2020-10-02 | 2026-11-02 |
| Irritability in Children With ADHD and Emotion Dysregulation Methylphenidate, aripiprazole, and combination - Irritable Mood, ADHD | Phase 4 | Completed | Tri-Service General Hospital (TSGH) | 36 | 2017-04-21 | 2023-08-07 |
| Network Connectivity and Inhibitory Control Under Atomoxetin Challenge- A Pharmacological 'Resting State' and 'Inhibiton Task' Study in Patients With ADHD Atomoxetine, Placebos - ADHD | Phase 4 | Completed | RWTH Aachen University | 38 | 2016-05-01 | 2018-09-07 |
| The Effects of ADHD Medication (TEAM) Study OROS-Methylphenidate (MPH) - ADHD | Phase 4 | Completed | Children's Hospital Medical Center, Cincinnati | 204 | 2015-01-12 | 2023-12-21 |
| Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study Very Low Dose Quillivant XR, Low Dose Quillivant XR, Moderate Dose Quillivant XR - ADHD, Autism | Phase 4 | Completed | Seattle Children's Hospital | 36 | 2014-09-01 | 2017-08-01 |
| A Study of Combination Therapy in Children With ADHD Methylphenidate ER, Cyproheptadine - ADHD, Attention Deficit Hyperactivity Disorder | Phase 4 | Completed | Douglas Sears | 99 | 2014-03-01 | 2015-04-10 |
| Methylphenidate for Attention Problems After Pediatric TBI Methylphenidate, Placebo - Traumatic Brain Injury, TBI | Phase 4 | Completed | Children's Hospital Medical Center, Cincinnati | 26 | 2013-11-01 | 2020-06-04 |
| Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation Lisdexamfetamine - ADHD | Phase 4 | Completed | Jeffrey Newcorn | 30 | 2013-03-01 | 2018-06-06 |
| Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach fMRI scans, Atomoxetine arm, Methylphenidate arm - Attention Deficit Hyperactivity Disorder, ADHD | Phase 4 | Completed | Icahn School of Medicine at Mount Sinai | 127 | 2012-10-01 | 2020-07-24 |
| Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist SODAS MPH, Naltrexone - ADHD, Stimulant-Induced Euphoria | Phase 4 | Completed | Massachusetts General Hospital | 37 | 2012-09-01 | 2016-11-30 |
| Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD Guanfacine Hydrochloride XR, Placebo - ADHD, Attention Deficit Hyperactivity Disorder | Phase 4 | Completed | Icahn School of Medicine at Mount Sinai | 27 | 2011-03-01 | 2018-02-14 |
| Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance? lisdexamfetamine - ADHD | Phase 4 | Completed | Florida International University | 38 | 2010-11-01 | 2014-06-13 |
| Evaluation of an Intervention for Improving Community-based Pediatric Attention-Deficit Hyperactivity Disorder (ADHD) Care ADHD Collaborative - ADHD | Phase 4 | Completed | Children's Hospital Medical Center, Cincinnati | 577 | 2010-05-01 | 2016-11-08 |
| Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS memantine hydrochloride - ADHD | Phase 4 | Completed | Massachusetts General Hospital | 34 | 2007-03-01 | 2012-06-07 |
| Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate OROS methylphenidate, No intervention - ADHD | Phase 4 | Completed | Massachusetts General Hospital | 39 | 2006-11-01 | 2012-08-31 |
| Study of Medication Patch to Treat Children Ages 6-12 With ADHD Methylphenidate Transdermal System, Placebo - ADHD, Attention Deficit Hyperactivity Disorder | Phase 4 | Completed | Massachusetts General Hospital | 36 | 2006-09-01 | 2012-11-16 |
| Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy atomoxetine (Strattera) - ADHD | Phase 4 | Completed | Massachusetts General Hospital | 30 | 2004-09-01 | 2010-06-22 |
| Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months) Atomoxetine Hydrochloride, placebo - ADHD | Phase 4 | Completed | Eli Lilly and Company | 440 | 2004-09-01 | 2007-11-06 |
| Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse Atomoxetine, placebo - ADHD, Comorbid Alcohol Abuse | Phase 4 | Completed | Eli Lilly and Company | 140 | 2004-08-01 | 2007-11-06 |
| Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD Atomoxetine and OROS Methylphenidate - ADHD, Attention Deficit Hyperactivity Disorder | Phase 4 | Completed | Massachusetts General Hospital | 94 | 2004-01-01 | 2012-11-14 |
Showing 20 of 27. Sign in to see all of them.
Attention Deficit Disorder with Hyperactivity (27) · Spasm (2) · Attention Deficit and Disruptive Behavior Disorders (1) · Autistic Disorder (1) · Bipolar Disorder (1) · Brain Injuries, Traumatic (1) · Cigarette Smoking (1) · Down Syndrome (1) · Neurodevelopmental Disorders (1) · Substance-Related Disorders (1)
Mental Disorders (27) · Attention Deficit and Disruptive Behavior Disorders (26) · Neurodevelopmental Disorders (26) · Nervous System Diseases (4) · Neurologic Manifestations (3) · Neuromuscular Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Abnormalities, Multiple (1) · Autism Spectrum Disorder (1) · Behavior (1) · Bipolar and Related Disorders (1) · Brain Diseases (1) · Brain Injuries (1) · Central Nervous System Diseases (1)
Methylphenidate (16) · Atomoxetine Hydrochloride (7) · Lisdexamfetamine Dimesylate (2) · 5,10-dihydro-5-methylphenazine (1) · Aripiprazole (1) · Cyproheptadine (1) · Galantamine (1) · Memantine (1) · Naltrexone (1) · SLI381 (1)
Massachusetts General Hospital (10) · Children's Hospital Medical Center, Cincinnati (4) · Eli Lilly and Company (2) · Icahn School of Medicine at Mount Sinai (2) · Douglas Sears (1) · Florida International University (1) · Jeffrey Newcorn (1) · RWTH Aachen University (1) · Seattle Children's Hospital (1) · Shire (1) · Tri-Service General Hospital (TSGH) (1) · University of Illinois at Chicago (1) · Utrecht Institute for Pharmaceutical Sciences (1)
United States (24) · Canada (1) · Germany (1) · Netherlands (1) · Taiwan (1)
Joseph Biederman, MD (5) · Jeffrey Newcorn, MD (3) · Paul Hammerness, MD (2) · Timothy Wilens, MD (2) · Anna Esbensen, PhD (1) · Benjamin Handen, MD (1) · Brad Kurowski, MS, MD (1) · Chin-Bin Yeh, MD., PhD. (1) · Edmund Volkerts, PhD (1) · James G Waxmonsky, M.D. (1) · Joris Verster, PhD (1) · Jose M Schuster, MD (1) · Kathleen Angkustsiri, MD (1)
PMID 25019647, PMID 14595084, PMID 15827573, PMID 16371674, PMID 19142107, PMID 19394037, PMID 20492851, PMID 20645078, PMID 21143432, PMID 21303732, PMID 22029549, PMID 23639146, PMID 24796970, PMID 25575616, PMID 25659477, PMID 27462065, PMID 27991835, PMID 28640990, PMID 29617066, PMID 29661516, PMID 30169436, PMID 38101205, PMID 38824626, PMID 40238929
R01MH083665 (1), R01MH095766 (1)